Back to Agenda
SESSION 4: WHAT DO TO WITH THE RESULTS OF IMPACT EVALUATIONS – ARE WE READY FOR THE CHANGE?
Session Chair(s)
Gonzalo Calvo Rojas, PHD
Consultant in Clinical Pharmacology, Hospital Clinic Barcelona, Spain
Emma Du Four, MBA
Independent Regulatory and R&D Policy Professional, Independent, United Kingdom
This session will provide the opportunity to discuss amongst all stakeholders the future direction of pharmacovigilance with the aim to focus resources on those activities where impact research provides the required evidence for change.
Speaker(s)
Patient and healthcare professional engagement in impact evaluation of regulatory decision-making
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy), European Medicines Agency, Netherlands
Impact of regulatory risk communication on public health outcomes – challenges and opportunities
NHS Research Scotland Primary Care Research Champion, University of Dundee, United Kingdom
Outline of a process to identify intended (and unintended) public health outcomes of regulatory decisions
Professor, Personal research chair, Department of Nursing, College of Human and Health Sciences, Swansea University, United Kingdom
Panel Discussion
Director, International Patient Collaboration, EUPATI Spain, Spain
Have an account?